Open Official source
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
- Funding
- $3–$500K≈ €449K
- Deadline
- 30 Oct 2026Closes tomorrow
- Location
- United States
Overview
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.
Eligibility
Businesses are listed among eligible applicants.
Eligible applicants
- Special district governments
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Public and State controlled institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Small businesses
- Independent school districts
- Native American tribal organizations (other than Federally recognized tribal governments)
- State governments
- County governments
- City or township governments
- Native American tribal governments (Federally recognized)
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Public housing authorities/Indian housing authorities
- For profit organizations other than small businesses
Funding details
- Amount per award
- $3–$500K≈ €449K
- Currency
- USD
Important dates
- Published
- 18 Jun 2026
- Deadline
- 30 Oct 2026